Anavex Life Sciences Corp (AVXL)
R&D Expense Growth
-10.15%
Fiscal year · Period ending:
AVXL R&D Expense Growth
Latest reported-10.15%period ending
Latest reported-10.15%period ending
AVXL FY R&D Growth (YoY) (0.00% → -10.15%)
Latest values, visible window
High-resolution chart · PNG
AVXL r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -10.1487% | |
| -4.2981% | |
| 15.2996% | |
| 14.9527% | |
| 30.7248% | |
| 13.3478% | |
| 66.8139% | |
| 25.0404% | |
| 47.1139% | |
| 219.3286% | |
| 210.1791% | |
| 177.5832% | |
| -90.058% | |
| 2.1785% | |
| -4.821% | |
| 27.528% | |
| 44.6313% | |
| 54.1612% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |